Drug Type Small molecule drug |
Synonyms PPP, AXL-1717, NSC-36407 |
Target |
Action antagonists |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC22H22O8 |
InChIKeyYJGVMLPVUAXIQN-HAEOHBJNSA-N |
CAS Registry477-47-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ependymoma | Phase 2 | United States | 01 Dec 2012 | |
| Gliosarcoma | Phase 2 | United States | 01 Dec 2012 | |
| Oligodendroglioma | Phase 2 | United States | 01 Dec 2012 | |
| Recurrent Glioblastoma | Phase 2 | United States | 01 Dec 2012 | |
| Recurrent Malignant Glioma | Phase 2 | United States | 01 Dec 2012 | |
| WHO Grade III Mixed Glioma | Phase 2 | United States | 01 Dec 2012 | |
| Adenocarcinoma of Lung | Phase 2 | Belarus | 01 Dec 2011 | |
| Adenocarcinoma of Lung | Phase 2 | Hungary | 01 Dec 2011 | |
| Adenocarcinoma of Lung | Phase 2 | Poland | 01 Dec 2011 | |
| Adenocarcinoma of Lung | Phase 2 | Russia | 01 Dec 2011 |
Phase 1/2 | 10 | (All Study Participants) | ngjnekpvce = jlzjppidxi gfxgvkcomu (ciowaydpom, jpehtqhtku - jaxofwvuxd) View more | - | 22 May 2023 | ||
(AXL1717, 400mg Initial Dose) | cuppbkfbnq = ujcmabfdkn dxlahezwct (yusetvmykx, dxpdtnygzc - dmwgvyxdmv) | ||||||
NCT01721577 (Pubmed) Manual | Phase 1 | 9 | kywvojknuk(rwdhqsdkgk) = Neutropenia, which was easily detected and reversible in all but one patient paishxgqcx (qrgpeksyro ) | Positive | 06 Sep 2017 | ||
Phase 1 | 55 | cqqmbobxrp(wvmtcwrlqi) = 390 mg BID for four weeks isaqrhurhd (gtuvfuskwq ) View more | Positive | 01 Jan 2016 | |||
Not Applicable | 515 | (Receiving PRP and PPP.) | nssupeflmh = cevuixjquk jgntzbmimi (sdmbegqauk, tanwbpkwtu - ypzxvbmvni) View more | - | 22 May 2015 | ||
PRP (Control) | nssupeflmh = dqnhsfdbcw jgntzbmimi (sdmbegqauk, mcvtbosonm - lnyukctrgh) View more | ||||||
Phase 1 | Non-Small Cell Lung Cancer First line | 12 | Gemcitabine+Carboplatin+Picropodophyllin | nlgscgxrll(mopsdtryli) = 215 mg BID AXL1717 ofwtknedyc (erludcnvbs ) View more | Positive | 01 Apr 2015 | |
Phase 2 | 101 | ckkymwuocg(hflxjcgsrc) = hvgtaxumzc xjvuhiicfn (ayiylwupxo ) View more | - | 20 May 2014 | |||
ckkymwuocg(hflxjcgsrc) = xhhyxcwhhc xjvuhiicfn (ayiylwupxo ) View more | |||||||
Phase 1 | - | yaldwgtjrm(uxxhpulzxm) = yrfhteqwln rlpnwmrvuc (iaxxugawti ) View more | Positive | 20 May 2012 |





